Onconetix, Inc. Files 8-K: Material Agreement, Financial Obligation, Delisting Notice

Ticker: ONCO · Form: 8-K · Filed: 2025-05-22T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, financial-obligation, delisting-notice

TL;DR

Onconetix 8-K: Material agreement, financial obligation, and potential delisting notice filed May 16, 2025.

AI Summary

Onconetix, Inc. filed an 8-K on May 22, 2025, reporting a material definitive agreement, a direct financial obligation, and a notice of delisting or failure to meet listing standards. The filing date for the earliest event reported was May 16, 2025. The company was formerly known as Blue Water Biotech, Inc. and Blue Water Vaccines Inc.

Why It Matters

This 8-K filing indicates significant financial and operational events for Onconetix, Inc., including potential delisting, which could impact its stock trading and investor confidence.

Risk Assessment

Risk Level: high — The notice of delisting or failure to satisfy a continued listing rule is a significant risk factor for investors.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement reported by Onconetix, Inc.?

The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the excerpt.

What is the direct financial obligation or off-balance sheet arrangement mentioned?

The filing states the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, but the specifics are not detailed in the provided text.

What is the reason for the notice of delisting or failure to satisfy a continued listing rule?

The filing includes a notice of delisting or failure to satisfy a continued listing rule, but the specific reasons for this notice are not elaborated in the excerpt.

When was Onconetix, Inc. formerly known as Blue Water Biotech, Inc.?

The date of the name change from Blue Water Biotech, Inc. to Onconetix, Inc. was April 24, 2023.

What is the SIC code for Onconetix, Inc.?

The Standard Industrial Classification (SIC) code for Onconetix, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

From the Filing

0001213900-25-046909.txt : 20250522 0001213900-25-046909.hdr.sgml : 20250522 20250522171057 ACCESSION NUMBER: 0001213900-25-046909 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250516 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250522 DATE AS OF CHANGE: 20250522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Onconetix, Inc. CENTRAL INDEX KEY: 0001782107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41294 FILM NUMBER: 25978222 BUSINESS ADDRESS: STREET 1: 201 E. FIFTH STREET STREET 2: SUITE 1900 CITY: CINCINNATI STATE: OH ZIP: 45202 BUSINESS PHONE: 513-620-4101 MAIL ADDRESS: STREET 1: 201 E. FIFTH STREET STREET 2: SUITE 1900 CITY: CINCINNATI STATE: OH ZIP: 45202 FORMER COMPANY: FORMER CONFORMED NAME: Blue Water Biotech, Inc. DATE OF NAME CHANGE: 20230424 FORMER COMPANY: FORMER CONFORMED NAME: Blue Water Vaccines Inc. DATE OF NAME CHANGE: 20190710 8-K 1 ea0243287-8k_onconetix.htm CURRENT REPORT false 0001782107 0001782107 2025-05-16 2025-05-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): May 16, 2025   Onconetix, Inc. (Exact name of registrant as specified in its charter)   Delaware   001-41294   83-2262816 (State or other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   201 E. Fifth Street , Suite 1900 Cincinnati , Ohio   45202 (Address of Principal Executive Offices)   (Zip Code)   Registrant’s telephone number, including area code: ( 513 ) 620-4101     (Former name or former address, if changed since last report.)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered Common Stock, par value $0.00001 per share   ONCO   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☒   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐           Item 1.01. Entry Into a Material Definitive Agreement   On May 16, 2025, Onconetix, Inc. (the “ Company ”) issued a promissory note

View on Read The Filing